These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 25386722
1. Reduced production of OprM may promote oprD mutations and lead to imipenem resistance in Pseudomonas aeruginosa carrying an oprD-group 1A allele. Shu JC, Su LH, Chiu CH, Kuo AJ, Liu TP, Lee MH, Su IN, Wu TL. Microb Drug Resist; 2015 Apr; 21(2):149-57. PubMed ID: 25386722 [Abstract] [Full Text] [Related]
6. Development of carbapenem resistance in Pseudomonas aeruginosa is associated with OprD polymorphisms, particularly the amino acid substitution at codon 170. Shu JC, Kuo AJ, Su LH, Liu TP, Lee MH, Su IN, Wu TL. J Antimicrob Chemother; 2017 Sep 01; 72(9):2489-2495. PubMed ID: 28535274 [Abstract] [Full Text] [Related]
9. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France. Diene SM, L'homme T, Bellulo S, Stremler N, Dubus JC, Mely L, Leroy S, Degand N, Rolain JM. Int J Antimicrob Agents; 2013 Sep 01; 42(3):268-71. PubMed ID: 23880169 [Abstract] [Full Text] [Related]
10. Carbapenem-resistant-only Pseudomonas aeruginosa infection in patients formerly infected by carbapenem-susceptible strains. Tsai MH, Wu TL, Su LH, Lo WL, Chen CL, Liang YH, Chiu CH. Int J Antimicrob Agents; 2014 Dec 01; 44(6):541-5. PubMed ID: 25264129 [Abstract] [Full Text] [Related]
12. Mechanisms of carbapenem resistance in cephalosporin-susceptible Pseudomonas aeruginosa in China. Zeng ZR, Wang WP, Huang M, Shi LN, Wang Y, Shao HF. Diagn Microbiol Infect Dis; 2014 Mar 01; 78(3):268-70. PubMed ID: 24359931 [Abstract] [Full Text] [Related]
15. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa. Pan YP, Xu YH, Wang ZX, Fang YP, Shen JL. Arch Microbiol; 2016 Aug 01; 198(6):565-71. PubMed ID: 27060003 [Abstract] [Full Text] [Related]
16. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. Riera E, Cabot G, Mulet X, García-Castillo M, del Campo R, Juan C, Cantón R, Oliver A. J Antimicrob Chemother; 2011 Sep 01; 66(9):2022-7. PubMed ID: 21653605 [Abstract] [Full Text] [Related]
17. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals. Wang J, Zhou JY, Qu TT, Shen P, Wei ZQ, Yu YS, Li LJ. Int J Antimicrob Agents; 2010 May 01; 35(5):486-91. PubMed ID: 20185276 [Abstract] [Full Text] [Related]
18. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR. Arabestani MR, Rajabpour M, Yousefi Mashouf R, Alikhani MY, Mousavi SM. Arch Iran Med; 2015 Feb 01; 18(2):102-8. PubMed ID: 25644798 [Abstract] [Full Text] [Related]
19. Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa. Wi YM, Choi JY, Lee JY, Kang CI, Chung DR, Peck KR, Song JH, Ko KS. Antimicrob Agents Chemother; 2017 Jun 01; 61(6):. PubMed ID: 28373200 [Abstract] [Full Text] [Related]